On Instagram, the artist shared how he received his diagnosis of acute myeloid leukemia (AML ... I hope to be out the other side of the initial treatment in 6–8 months' time." ...

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...

The Statesboro community is rallying behind U.S. Army veteran Matthew Kleinsorge, a devoted father of four, as he battles ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

The following is a summary of “Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

Braylee Littig, battling leukemia, surprises her West Central basketball teammates, bringing joy and inspiration during a ...

SAN FRANCISCO, CA, USA I7, 2025 I GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing ...

Carterville High School will hold an “Orange Out” fundraiser on Feb. 1 to support assistant coach and teacher Eli Gunther as ...

Around one-third of patients with acute myeloid leukemia (AML) harbor FLT3 gene mutations which are associated with poor prognosis and high risk of relapse. Several compounds targeting FLT3 internal ...

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...